Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study

  1. Daniele, B.
  2. Croitoru, A.
  3. Papandreou, C.
  4. Bronowicki, J.-P.
  5. Mathurin, P.
  6. Serejo, F.
  7. Stål, P.
  8. Turnes, J.
  9. Ratziu, V.
  10. Bodoky, G.
Journal:
Future Oncology

ISSN: 1744-8301 1479-6694

Year of publication: 2015

Volume: 11

Issue: 18

Pages: 2553-2562

Type: Article

DOI: 10.2217/FON.15.163 GOOGLE SCHOLAR

Sustainable development goals